AbbVie Provides Update Regarding RINVOQ (upadacitinib) in Psoriatic Arthritis and Ankylosing Spondylitis in the U.S.

Mount Carmel Register

Jun 25, 2021

AbbVie Provides Update Regarding RINVOQ (upadacitinib) in Psoriatic Arthritis and Ankylosing Spondylitis in the U.S. |!| Mount Carmel